(S (NP-SBJ Calcineurin/NN mutants/NNS) (VP render/VBP (S (NP-SBJ T/NN lymphocytes/NNS) (ADJP-PRD resistant/JJ (PP to/TO (NP cyclosporin/NN A/NN))))) ./.)
(S (NP-SBJ-29 The/DT immunosuppressants/NNS (NP-COOD (NP (NP cyclosporin/NN A/NN) (PRN -LRB-/-LRB- (NP CsA/NN) -RRB-/-RRB-)) and/CC (NP FK506/NN))) (VP have/VBP (VP been/VBN (ADVP widely/RB) (VP used/VBN (NP-30 *-29/-NONE-) (S (NP-SBJ *-30/-NONE-) (VP to/TO (VP (VP-COOD (VP prevent/VB (NP *RNR*-31/-NONE-)) and/CC (VP treat/VB (NP *RNR*-31/-NONE-))) (NP-31 (NP graft/NN rejection/NN) (PP-TMP after/IN (NP human/JJ (NP-COOD (NP organ/NN) and/CC (NP tissue/NN)) transplantations/NNS))))))))) ./.)
(S (NP-SBJ-COOD-32 (NP CsA/NN) and/CC (NP FK506/NN)) (VP associate/VBP (PP with/IN (NP (NP intracellular/JJ binding/VBG proteins/NNS) (PRN -LRB-/-LRB- (NP (ADVP i.e./FW) ,/, (NP-COOD (NP (NP CsA/NN) (PP with/IN (NP cyclophilin/NN A/NN))) and/CC (NP (NP FK506/NN) (PP with/IN (NP FKBP12/NN))))) -RRB-/-RRB-))) (S (NP-SBJ *-32/-NONE-) (VP to/TO (VP form/VB (NP (NP protein\/drug/NN complexes/NNS) (SBAR (WHNP-33 that/WDT) (S (NP-SBJ-34 *T*-33/-NONE-) (VP suppress/VBP (NP the/DT immune/JJ system/NN) (PP by/IN (S (NP-SBJ *-34/-NONE-) (VP preventing/VBG (NP (NP activation/NN) (PP of/IN (NP T/NN cells/NNS)) (PP in/IN response/NN to/TO (NP antigen/NN presentation/NN)))))))))))))) ./.)
(S (NP-SBJ (NP The/DT common/JJ target/NN) (PP of/IN (NP-COOD (NP CsA/NN) and/CC (NP FK506/NN)))) (VP is/VBZ (NP-PRD (NP calcineurin/NN) ,/, (NP (NP a/DT (ADJP-COOD (ADJP Ca2+\/calmodulin-regulated/JJ) ,/, (ADJP serine\/threonine-specific/JJ)) protein/NN phosphatase/NN) (SBAR (WHNP-35 that/WDT) (S (NP-SBJ *T*-35/-NONE-) (VP regulates/VBZ (NP (NP the/DT nuclear/JJ import/NN) (PP of/IN (NP (NP (NP a/DT transcription/NN factor/NN) ,/, (NP NF-AT/NN) ,/,) (VP required/VBN (NP */-NONE-) (PP for/IN (NP (NP expression/NN) (PP of/IN (NP T/NN cell/NN activation/NN genes/NNS)))))))))))))) ./.)
(S (PP In/IN (NP previous/JJ studies/NNS)) ,/, (NP-SBJ we/PRP) (VP identified/VBD (NP (NP calcineurin/NN mutations/NNS) (SBAR (WHNP-36 that/WDT) (S (NP-SBJ *T*-36/-NONE-) (VP-COOD (VP block/VBP (NP (NP binding/NN) (PP by/IN (NP the/DT (ADJP-COOD (ADJP cyclophilin/NN A\/CsA/NN) or/CC (ADJP FKBP12\/FK506/NN)) complexes/NNS)))) and/CC thereby/RB (VP render/VBP (S (NP-SBJ yeast/NN cells/NNS) (ADJP-PRD resistant/JJ (PP to/TO (NP (NP the/DT antifungal/JJ effects/NNS) (PP of/IN (NP-COOD (NP CsA/NN) or/CC (NP FK506/NN))))))))))))) ./.)
(S (PP In/IN (NP this/DT report/NN)) ,/, (NP-SBJ we/PRP) (VP demonstrate/VBP (SBAR that/IN (S (NP-SBJ (NP the/DT corresponding/JJ mutations/NNS) (PP in/IN (NP murine/JJ calcineurin/NN))) (VP render/VBP (S (NP-SBJ the/DT T/NN cell/NN receptor/NN signal/NN transduction/NN cascade/NN CsA/NN) (ADJP-PRD resistant/JJ (PP in/IN (NP human/JJ Jurkat/NN T/NN cells/NNS)))))))) ./.)
(S (NP-SBJ Our/PRP$ findings/NNS) (VP-COOD (VP support/VBP (NP the/DT (ADJP recently/RB determined/VBN) calcineurin/NN X-ray/NN crystal/NN structure/NN)) ,/, (VP provide/VBP (NP evidence/NN (SBAR that/IN (S (NP-SBJ calcineurin/NN) (VP is/VBZ (NP-PRD (NP the/DT only/RB CsA-sensitive/JJ component/NN) (VP limiting/VBG (NP (NP signaling/NN) (PP from/IN (NP the/DT T/NN cell/NN receptor/NN)) (PP to/TO (NP the/DT nucleus/NN)))))))))) ,/, and/CC (VP suggest/VBP (NP (NP a/DT means/NN) (SBAR (WHADVP-37 0/-NONE-) (S (NP-SBJ */-NONE-) (VP to/TO (VP render/VB (S (NP-SBJ-COOD (NP cells/NNS) and/CC (NP tissues/NNS)) (ADJP-PRD resistant/JJ (PP to/TO (NP (NP the/DT toxic/JJ side/JJ effects/NNS) (PP of/IN (NP-COOD (NP CsA/NN) and/CC (NP FK506/NN))))))) (ADVP *T*-37/-NONE-)))))))) ./.)
